Heterotopic ossification prophylaxis with etoricoxib versus diclofenac after THA
Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenacInt Orthop. 2016 Apr;40(4):673-80
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
100 patients scheduled for total hip arthroplasty were randomized to one of two different oral non-steroid anti-inflammatory drugs (NSAIDs) for heterotopic ossification (HO) prophylaxis; etoricoxib or diclofenac. Patients were assessed over a 6 -month follow-up for the development of HO. Results demonstrated no significant differences between groups in the development of HO. No patient of either g...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue